IRCT2017062134670N1已完成2 期
Comparison of modify Doxotel, Cisplatin, 5fluoracil versus Eloxatin chemotherapy regimens in terms of overall survival and progression free survival in patients with advanced gastric and gastroesophageal junction cancer
Vice chancellor for research , Jondy Shapor University of Medical Sciences0 个研究点目标入组 180 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 180
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit（—）
- 性别
- All
入选标准
- •Inclusion major eligibility criteria : female and male ;18 until 65 years; functional class; critria for histology of adenocarcinoma gastric and Gastroesophageal junction; not finding for family geoghrafic psyicatric state with effect for ejucation;
- •exclusion major eligibility criteria : peripheral nouropathy ; Cerebrovascular disease ;Myocardial infarction ; Pulmonary thrombo emboly ; unstable angina ; uncontrol infection ; pregnancy and lactation ; previce medication for adenocarcinoma; lower limd artritic ; thyapy with phenytoin; known malignancy;
排除标准
- 未提供
研究者
相似试验
尚未招募
2 期
Comparing two types of chemotherapy in breast cancerCTRI/2017/10/010272Jawaharlal Institute of Post Graduate Medical Education and research
已完成
2 期
Phase II study of docetaxel/cisplatin/5-fluorouracil combination chemotherapy for advanced esophageal canceresophageal cancerJPRN-UMIN000008400Jikei university school of medicine, department of oncology and hematology, department of gastroenterological surgery60
Unknown
3 期
Docetaxol Plus Cisplatin Versus 5-Fu Plus Cisplatin as 1st-line Chemotherapy in Advanced ESCC PatientsEsophagus CancerChemotherapy EffectsNCT03002064Sun Yat-sen University358
进行中（未招募）
1 期
A Phase II Trial of docetaxel, cisplatin and 5FU chemotherapy in locally advanced and metastatic carcinoma of the penis - Penile TPFocally advanced and metastatic carcinoma of the penisMedDRA version: 13.1Level: LLTClassification code 10034299Term: Penile cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2008-000707-28-GBThe Institute of Cancer Research29
已完成
3 期
Randomized comparative study of cisplatin, docetaxel, and irinotecan versus cisplatin and docetaxel in patients with stage IIIB or stage IV non-small cell lung cancer (OLCSG 0403)JPRN-C000000205Okayama Lung Cancer Study Group (OLCSG)120